Dr. Janice M R Staber, MD is a pediatric oncologist in Iowa City, IA specializing in pediatric hematology/oncology and general pediatrics. She graduated from University of Iowa, Carver College of Medicine. Dr. Janice M R Staber, MD is affiliated with University of Iowa Health Care.
200 Hawkins Drive
Iowa City, IA 52242
Hemophilia
Hemophilia is a bleeding disorder in which blood cannot clot normally. After an injury, people who have hemophilia bleed longer because they lack certain blood proteins that are responsible for clotting, called clotting factors. Some hemophiliacs are mildly deficient in this protein, so they bleed only when injured or after surgery. Those who are severely deficient, however, may experience symptoms of spontaneous bleeding, including the following:
Most people with hemophilia have a family history of the disorder, though about 30% do not. The most common forms are hemophilia A (classic hemophilia) and hemophilia B (Christmas disease). Hemophilia A and B share certain characteristics, but different genes are involved. Acquired hemophilia is very rare and has been linked to autoimmune conditions, cancer, and multiple sclerosis.
Hemophilia may be diagnosed using a blood test. If there is family history of the disorder, testing may be done prenatally. Treatment involves regular intravenous replacement of clotting factors, which may be produced in a laboratory (recombinant) or come from blood donors. For people with milder forms of the disease, a hormone called desmopressin may stimulate the body to produce clotting factors. Other drug therapies include medications that help slow the breakdown of blood clots and medications that are applied directly to the wound to promote clotting.
Living with hemophilia can be challenging, but simple things may help prevent excessive bleeding. For example, choosing activities like walking or swimming over contact sports can prevent injuries and strengthen muscles while protecting the joints. Chances for bleeding may also be reduced by making sure that children wear helmets and elbow pads during activities like bicycle rides.
Platelet Disorders
Platelet disorders are conditions caused by abnormally low or high levels of platelets in the blood, or by platelets that do not function correctly. Platelets are small blood cells that help stop bleeding by clumping together and forming blood clots, allowing the body to heal.
Thrombocytopenia is a disorder where people have too few platelets. With too few platelets in the bloodstream, the blood is unable to properly clot. People with thrombocytopenia may experience prolonged external and internal bleeding. Large purple bruises (ecchymoses) and small red skin spots (petechiae) in the skin and mouth are common in those with thrombocytopenia. Other symptoms of the disorder include bleeding gums, blood in bodily fluids, and fatigue. Thrombocytopenia most often arises from a different condition or treatment, such as alcoholism, autoimmune disease, cancer treatments, viruses (such as Hepatitis C and HIV), bone marrow diseases (such as leukemia and aplastic anemia), enlarged spleen, and exposure to toxic chemicals. In rare cases, thrombocytopenia is inherited.
Thrombocytosis is a disorder where people have too high of a concentration of platelets. Excess platelets can cause blood to clot in the veins. Blood clots in the veins are particularly dangerous, as they can obstruct blood flow and cause heart attacks and strokes. Thrombocytosis has two forms:
If a doctor suspects a patient has a platelet disorder, a complete blood count (CBC) or platelet count test helps determine the concentration of platelets in a person's blood at a given time. Platelet disorders can be diagnosed by hematologists using advanced tests on platelet samples. Flow cytometry tests detect abnormalities by evaluating the characteristics of a platelet sample using targeted lasers and lights. Tests measuring prothrombin time (PT), or how long it takes for blood to clot, can also detect dysfunctional platelets. If platelets do not coagulate within a certain time frame, the patient most likely has dysfunctional platelets.
Treatments for low platelet counts include steroids like Prednisone, that can assist with platelet production. If a patient's low platelet count is caused by spleen problems, spleen removal (splenectomy) may be recommended. To treat the prolonged bleeding caused by thrombocytopenia, doctors frequently prescribe Dempressin, a hormone that promotes blood clotting. Antifibrinolytic medications such as tranexamic acid may also aid in the promotion of clotting and the prevention of bleeding. For patients with severe platelet disorders (either low platelet count and dysfunctional platelets), blood transfusions may be prescribed. Platelet blood transfusions deliver donated platelets to patients intravenously, replenishing the volume of functioning platelets.
Patients with high platelet counts are frequently prescribed a daily dose of over-the-counter medication aspirin. Platelet-lowering medications, such as hydroxyurea and Intron A, may reduce the likelihood of blood clot formation. Excess platelets may also be removed from the blood by a procedure called plateletpheresis or platelet reduction apheresis, where blood is drawn, circulated into a centrifuge that separates the blood components, and returned to the body with some platelets extracted. Plateletpheresis is a rare procedure reserved for patients who have severe clotting.
Patients can also modify their lifestyle to better manage their disorder and minimize complications. Patients with low blood counts should avoid blood-thinning medications, alcohol, and activities that could lead to injury. Patients with high blood count are advised to drink plenty of water, exercise regularly, and to avoid smoking. Many people with platelet disorders can live healthy and fulfilling lives with proper treatment and precautions.
Dr. Janice M R Staber, MD graduated from University of Iowa, Carver College of Medicine. She is certified by the American Board of Pediatric Hematology/Oncology American Board of Pediatrics Diagnosis and Management of Coagulation Disorders and has a state license in Iowa.
Medical School: University of Iowa, Carver College of Medicine
Board Certification: American Board of Pediatric Hematology/Oncology American Board of Pediatrics Diagnosis and Management of Coagulation Disorders
Licensed In: Iowa
Dr. Janice M R Staber, MD is associated with these hospitals and organizations:
Dr. Janice M R Staber, MD has an exceptional overall rating with an average of 4.64 out of 5 stars based on 129 ratings. We collect ratings and reviews of Dr. Janice M R Staber, MD from all over the web to help you find the right in Iowa City, IA.
These charts describe general payments received by Dr. Janice M R Staber, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
Novo Nordisk AS |
$44,325
$44,325 |
|||||
---|---|---|---|---|---|---|
GENZYME CORPORATION |
$18,893
$18,893 |
|||||
Takeda Pharmaceuticals U.S.A., Inc. |
$12,363
$12,363 |
|||||
Genentech USA, Inc. |
$9,262
HEMLIBRA $9,262 |
|||||
Spark Therapeutics, Inc. |
$7,320
$7,320 |
|||||
Other |
$30,444
Jivi $5,897 |
Ixinity $4,802 |
NO PRODUCT DISCUSSED $3,542 |
NovoSeven $2,975 |
Idelvion $2,342 |
Other $10,885 |
Consulting Fee | $66,256 |
---|---|
Travel and Lodging | $46,970 |
Food and Beverage | $4,887 |
Honoraria | $2,320 |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,109 |
Other | $64 |
Dr. Janice M R Staber, MD has received 194 research payments totaling $545,822.
Dr. Janice Staber's medical specialty is pediatric hematology/oncology and general pediatrics. Her areas of expertise include the following: platelet disorders, thrombophilia (clotting disorders), and menorrhagia (heavy periods). Dr. Staber is affiliated with the University of Iowa Health Care. She is a graduate of the University of Iowa, Carver College of Medicine. The average patient rating for Dr. Staber is 4.5 stars (out of 5).